Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/123535
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: MicroRNAs as therapeutic targets and clinical biomarkers in atherosclerosis
Author: Solly, E.L.
Dimasi, C.G.
Bursill, C.A.
Psaltis, P.J.
Tan, J.T.M.
Citation: Journal of Clinical Medicine, 2019; 8(12):2199-1-2199-26
Publisher: MDPI
Issue Date: 2019
ISSN: 2077-0383
2077-0383
Statement of
Responsibility: 
Emma L. Solly, Catherine G. Dimasi, Christina A. Bursill, Peter J. Psaltis, and Joanne T.M. Tan
Abstract: Atherosclerotic cardiovascular disease remains the leading cause of morbidity and mortality worldwide. Atherosclerosis develops over several decades and is mediated by a complex interplay of cellular mechanisms that drive a chronic inflammatory milieu and cell-to-cell interactions between endothelial cells, smooth muscle cells and macrophages that promote plaque development and progression. While there has been significant therapeutic advancement, there remains a gap where novel therapeutic approaches can complement current therapies to provide a holistic approach for treating atherosclerosis to orchestrate the regulation of complex signalling networks across multiple cell types and different stages of disease progression. MicroRNAs (miRNAs) are emerging as important post-transcriptional regulators of a suite of molecular signalling pathways and pathophysiological cellular effects. Furthermore, circulating miRNAs have emerged as a new class of disease biomarkers to better inform clinical diagnosis and provide new avenues for personalised therapies. This review focusses on recent insights into the potential role of miRNAs both as therapeutic targets in the regulation of the most influential processes that govern atherosclerosis and as clinical biomarkers that may be reflective of disease severity, highlighting the potential theranostic (therapeutic and diagnostic) properties of miRNAs in the management of cardiovascular disease.
Keywords: Inflammation; oxidative stress; angiogenesis; endothelial dysfunction; smooth muscle cells; foam cell formation; plaque stability; plaque rupture; vasa vasorum
Rights: © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
RMID: 1000011268
DOI: 10.3390/jcm8122199
Grant ID: http://purl.org/au-research/grants/nhmrc/GNT1161506
Appears in Collections:Medicine publications

Files in This Item:
File Description SizeFormat 
hdl_123535.pdfPublished Version1.22 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.